Lambda interferon (IFN-X) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-γ-induced nitric oxide production

Journal of Virology

Volumn 81, Issue 16, 2007, Pages 8685-8691

  Stoltz, Malin ^a,b   Ahlm, Clas ^c   Lundkvist, Åke ^a,b   Klingström, Jonas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1BETA; LAMBDA INTERFERON; NITRIC OXIDE; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; HANTAVIRUS; HANTAVIRUS CARDIOPULMONARY SYNDROME; HOSPITALIZATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PUUMALA VIRUS; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

CELLS, CULTURED; CYTOKINES; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERONS; INTERLEUKIN-1BETA; INTERLEUKINS; NITRIC OXIDE; PHOSPHORYLATION; PULMONARY HEART DISEASE; STAT1 TRANSCRIPTION FACTOR; SYNDROME; VIRUS REPLICATION;

HANTAAN VIRUS; HANTAVIRUS; PUUMALA VIRUS;

EID: 34547729665     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00415-07     Document Type: Article

References (43)

1. Alff, P. J., I. N. Gavrilovskaya, E. Gorbunova, K. Endriss, Y. Chong, E. Geimonen, N. Sen, N. C. Reich, and E. R. Mackow. 2006. The pathogenic N.Y.-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 80:9676-9686.
2. Ank, N., H. West, and S. R. Paludan. 2006. IFN-λ: novel antiviral cytokines. J. Interferon Cytokine Res. 26:373-379.
3. Ank, N., H. West, C. Bartholdy, K. Eriksson, A. R. Thomsen, and S. R. Paludan. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509.
4. Bahl, K., S.-K. Kim, C. Calgagno, D. Ghersi, R. Puzone, F. Celada. L. K. Selin, and R. M. Welsh. 2006. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 176:4284-4295.
5. Bogdan, C., N. Rollinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26.
6. Cao, W., C. Bao, and C. J. Lowenstein. 2003. Inducible nitric oxide synthase expression inhibition by adenovirus E1A. Proc. Natl. Acad. Sci. USA 100:7773-7778.
7. 2, involves inhibition of the upstream Janus kinase/ signaling pathway. J. Immunol. 171:979-988.
8. Cunha, B. A., V. Minnaganti, D. H. Johnson, and N. C. Klein. 2003. Profound and prolonged lymphocytopenia with West Nile encephalitis. Clin. Infect. Dis. 31:1116-1117.
9. Davis, I. C., A. J. Zajac, K. B. Nolte, J. Botten, B. Hjelle, and S. Matalon. 2002. Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J. Virol. 76:8347-8359.
10. Fisher-Hoch, S. P., G. S. Platt, G. H. Neild, T. Southee, A. Baskerville, R. T. Raymond, G. Lloyd, and D. I. Simpson. 1985. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152:887- 894.
11. Frese, M., G. Kochs, H. Feldmann, C. Hertkorn, and O. Haller. 1996. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70:915-923.
12. Geimonen, E., R. LaMonica, K. Springer, Y. Farooqui, I. N. Gavrilovskaya, and E. R. Mackow. 2003. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 77:1638-1643.
13. Geimonen, E., S. Neff, T. Raymond, S. S. Kocer, I. N. Gavrilovskaya, and E. R. Mackow. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. USA 99:13837-13842.
14. Geisbert, T. W., and P. B. Jahrlin. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 12:S110-S121.
15. Granja, A. G., P. Sabina, M. L. Salas, M. Fresno, and Y. Revilla. 2006. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J. Virol. 80:10487-10496.
16. Haller, O., G. Kocks, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130.
17. Kamphuis, E., T. Junt, Z. Waibler, R. Forster, and U. Kalinke. 2006. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 108:3253-3261.
18. Kanerva, M., K. Melen, A. Vaheri, and I. Julkunen. 1996. Inhibition of Puumala and Tula hantaviruses in Vero cells by MxA protein. Virology 224:55-62.
19. Khaiboullina, S. F., and S. C. St Jeor. 2002. Hantavirus immunology. Viral Immunol. 15:609-625.
20. + T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172:3297-3304.
21. Klingström, J., J. Hardestam, M. Stoltz, B. Zuber, Å. Lundkvist, S. Linder, and C. Ahlm. 2006. Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J. Virol. 80:8279-8282.
22. Klingström, J., S. Åkerstrom. J. Hardestam, M. Stoltz, M. Simon, K. I. Falk, A. Mirazimi, M. Rottenberg, and Å. Lundkvist. 2006. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur. J. Immunol. 36:2649-2657.
23. Kotenko, S., V. G. Gallagher, V. V. Baurin, A. Lewis-Antes, M. Shen, N. K. Shah, J. A. Langer, F. Sheikh, H. Dickensheets, and R. P. Donnelly. 2003. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
24. Kraus, A. A., M. J. Raftery, T. Giese, T. R. Ulrich, R. Zawatzky, S. Hippenstiel, N. Suttorp, D. H. Kruger, and G. Schönrich. 2004. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J. Virol. 78:6143-6150.
25. Levis, S. C., M. C. Saavedra, C. Ceccoli, E. Falcoff, M. R. Feuillade, D. A. Enria, J. I. Maiztegui, and R. Falcoff. 1984. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149:428-433.
26. Linderholm, M., C. Ahlm, B. Settergren, A. Waage, and A. Tärnvik. 1996. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and 1L-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173:38-43.
27. Nahmias, A. J., D. Griffith, C. Salsbury, and K. Yoshida. 1967. Thymic aplasia with lymphopenia, plasma cells, and normal immunoglobulins. Relation to measles virus infection. JAMA 201:729-734.
28. Nam, J. H., K. A. Hwang, C. H. Yu, T. H. Kang, J. Y. Shin, W. Y. Choi, I. B. Kim, Y. R. Joo, H. W. Cho, and K. Y. Park. 2003. Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. Virus Genes 26:31-38.
29. Peiris, J. S., S. T. Lai, L. L. Poon, Y. Guan, L. Y. Yam, W. Lim, J. Nicholls, W. K. Yee, W. W. Yan, M. T. Cheung, V. C. Cheng, K. H. Chan, D. N. Tsang, R. W. Yung, T. K. Ng, and K. Y. Yuen. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325.
30. Prescott, J., C. Ye, G. Sen, and B. Hjelle. 2005. Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J. Virol. 79:15007-15015.
31. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
32. Scheinberg, M., N. R. Blacklow, A. L. Goldstein, T. A. Parrino, F. B. Rose, and E. S. Cathcart. 1976. Influenza: response of T-cell lymphopenia to thymosin. N. Engl. J. Med. 294:1208-1211.
33. Schmaljohn, C. S., and B. Hjelle. 1997. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3:95-104.
34. Sheppard, P., W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T. E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F. J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K. M. Klucher. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
35. Spiropoulou, C. F., C. G. Albarino, T. G. Ksiazek, and P. E. Rollin. 2007. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 81:2769-2776.
36. Stamler, J. S., D. J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258:1896-1902.
37. Stetson, D. B., and R. Medzhitov. 2006. Type I interferon in host defense. Immunity 25:373-381.
38. Tamura, M., H. Asada, K. Kondo, M. Takahashi, and K. Yamanishi. 1987. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res. 8:171-178.
39. Terajima, M., O. Vapalahti, H. L. Van Epps, A. Vaheri, and F. A. Ennis. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect. 6:238-245.
40. Van Epps, H. L., M. Terajima, J. Mustonen, T. P. Arstila, E. A. Corey, A. Vaheri, and F. A. Ennis. 2002. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196:579-588.
41. Vapalahti, O., J. Mustonen, Å. Lundkvist, H. Henttonen, A. Plyusnin, and A. Vaheri. 2003. Hantavirus infections in Europe. Lancet. Infect. Dis. 3:653-661.
42. Villinger, F., P. E. Rollin, S. S. Brar, N. F. Chikkala, J. Winter, J. B. Sundstrom, S. R. Zaki, R. Swanepoel, A. A. Ansari, and C. J. Peters. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179:S188-S191.
43. Xiao, R., S. Yang, F. Koster, C. Ye, C. Stidley, and B. Hjelle. 2006. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J. Infect. Dis. 194:1403-1409.